Startup / Overview

Today health institutions navigate a sea of unstructured and disorganised patient data. In the case of clinical and pharmaceutical research, this situation limits the efforts organisations can devote to developing new drugs or new medical devices, which costs billions of CHF from conception to market. 

RetinAI develops software to accelerate and support clinical & pharmaceutical research workflows, automating parts of the process. 

We collect, organise & analyse health data from the eyes, empowering communities of healthcare professionals with data analysis supported by computer vision, signal processing & AI. 

RetinAI Discovery® is our platform for supporting research and clinical decisions. It works on commodity hardware, works via the web browser inside the hospital and enables analysis and transfer of medical data from the eyes, connecting devices, data sources & decisions in a seamless and easy manner as a medical device. 

Startup / Connect

AMLD EPFL 2021 / Program

Neural Concept

Neural Concept Shape (NCS) is the commercial and industrial implementation of a software package developed at EPFL’s computer vision laboratory over the last 4 years. NCS is the first Deep-Learning software specifically tailored for Computer Assisted Engineering application.

Booth #101


We are engineers and data scientists on a mission to democratize the use of machine learning in the industry.

Booth #102


Visium is a fast-growing Swiss technology company dedicated to solving complex problems with cutting-edge AI of traditional industries like pharma, chemical, FMCG, MEM, banking and energy.

Booth #103

AMLD / Global partners